EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Small Molecule Drugs Targeting Viral Polymerases

Deborah Palazzotti, Martina Sguilla, Giuseppe Manfroni iD, Violetta Cecchetti iD, Andrea Astolfi iD, Maria Letizia Barreca iD

Pharmaceuticals · 20.05.2024 · 17 (5) · 661

DOI: 10.3390/ph17050661 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 20.05.2024. Verfasst von Deborah Palazzotti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan (NRRP) by the Italian Ministry of University and Research (MUR), EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases, INF-ACT Cascade Open Call 2023.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small molecules that specifically target viral polymerases—crucial enzymes governing viral genome transcription and replication—play a pivotal role in combating viral infections. Presently, approved polymerase inhibitors cover nine human viruses, spanning both DNA and RNA viruses. This review provides a comprehensive analysis of these licensed drugs, encompassing nucleoside/nucleotide inhibitors (NIs), non-nucleoside inhibitors (NNIs), and mutagenic agents. For each compound, we describe the specific targeted virus and related polymerase enzyme, the mechanism of action, and the relevant bioactivity data. This wealth of information serves as a valuable resource for researchers actively engaged in antiviral drug discovery efforts, offering a complete overview of established strategies as well as insights for shaping the development of next-generation antiviral therapeutics.

Schlagwörter

Stichwörter der Autor:innen

FDAdrugsinhibitorssmall moleculesviral polymeraseviruses

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy.

ORCID-Profile: Giuseppe Manfroni, Violetta Cecchetti, Andrea Astolfi, Maria Letizia Barreca

Förderung

  • National Recovery and Resilience Plan (NRRP) by the Italian Ministry of University and Research (MUR)
  • EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
  • INF-ACT Cascade Open Call 2023

Zitieren

APA

Palazzotti, D., Sguilla, M., Manfroni, G., Cecchetti, V., Astolfi, A., & Barreca, M. L. (2024). Small Molecule Drugs Targeting Viral Polymerases. Pharmaceuticals, 17(5), 661. https://doi.org/10.3390/ph17050661

Vancouver

Palazzotti D, Sguilla M, Manfroni G, Cecchetti V, Astolfi A, Barreca ML. Small Molecule Drugs Targeting Viral Polymerases. Pharmaceuticals. 2024;17(5):661. doi:10.3390/ph17050661

BibTeX
@article{Palazzotti2024,
  author = {Palazzotti, Deborah and Sguilla, Martina and Manfroni, Giuseppe and Cecchetti, Violetta and Astolfi, Andrea and Barreca, Maria Letizia},
  title = {Small Molecule Drugs Targeting Viral Polymerases},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {5},
  pages = {661},
  doi = {10.3390/ph17050661}
}
Kostenlos starten →